Bioactive plant molecules, sources and mechanism of action in the treatment of cardiovascular disease (Record no. 19704)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01929nam a22002417a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305193737.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 221125b |||||||| |||| 00| 0 eng d |
| 028 ## - PUBLISHER OR DISTRIBUTOR NUMBER | |
| Source | Phone: +255 28 298 3384 |
| Source | Fax: +255 28 298 3386 |
| Source | Email: vc@bugando.ac.tz |
| Source | Website: www.bugando.ac.tz |
| 040 ## - CATALOGING SOURCE | |
| Language of cataloging | English |
| Transcribing agency | DLC |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | AC Liwa |
| 9 (RLIN) | 45987 |
| 245 ## - TITLE STATEMENT | |
| Title | Bioactive plant molecules, sources and mechanism of action in the treatment of cardiovascular disease |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Mwanza, Tanzania: |
| Name of publisher, distributor, etc. | Catholic University of Health and Allied Sciences [CUHAS – Bugando] & |
| -- | Science Direct |
| Date of publication, distribution, etc. | 18 November 2016. |
| 490 ## - SERIES STATEMENT | |
| Volume/sequential designation | Pharmacognosy Fundamentals, Applications and Strategies |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Abstract:::<br/><br/>Cardiovascular diseases (CVDs) are a leading cause of global morbidity, mortality, and health care spending. The current goal of the United Nations is a 25% reduction in deaths owing to noncommunicable diseases such as CVDs by 2025. The economic costs of contemporary therapeutic approaches to reduce the major CVD risk factors of hyperlipidemia, atherosclerosis, and hypertension cannot be sustained on a global scale. Novel sources of bioactive molecules for use in low cost therapies will be essential to accomplish this goal. In this chapter, we review the natural products containing bioactivities for which compelling evidence of efficacy in ameliorating hyperlipidemia, atherosclerosis, and hypertension has been obtained in the laboratory or a clinical setting. The pathophysiological basis of hyperlipidemia, atherosclerosis, and hypertension and current synthetic drug therapies are reviewed and the major sources and candidate bioactive molecules as well as their postulated mechanism(s) of action are discussed. |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 45988 |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/B978-0-12-802104-0.00015-9">https://doi.org/10.1016/B978-0-12-802104-0.00015-9</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | RESEARCH ARTICLES |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 11/25/2022 | RA0912 | 11/25/2022 | RA0912 | 11/25/2022 | RESEARCH ARTICLES |